Physician profile
Muhammad Khan
NPI 1053670414
$4,010.58
in general payments reported to CMS, 2019-2025
16 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what 76% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2021: $144 · 2022: $280 · 2024: $1,686 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,017 · Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,016.88 |
| Food and Beverage | $1,154.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,526.80 | 2024 | Trufill, Emboguard, Cerepak Uniform |
| Penumbra, INC. | $1,304.05 | 2024-2025 | Penumbra System |
| Medtronic, INC. | $187.08 | 2025 | Axium Primetm, Pipeline |
| Imperative Care, INC | $153.17 | 2025 | Zoom 88-T Large Distal Platform |
| Eisai INC. | $125.00 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $120.32 | 2021 | |
| Lilly USA, LLC | $114.39 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $113.58 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $79.02 | 2019 | |
| Genzyme Corporation | $71.31 | 2019 | |
| Amgen INC. | $67.98 | 2019 | |
| Allergan, INC. | $41.05 | 2022 | |
| Ucb, INC. | $35.04 | 2022 | |
| Sk Life Science, INC. | $27.71 | 2022 | |
| Upsher-Smith Laboratories LLC | $24.08 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.